google-site-verification: googlec7193c3de77668c9.html

Stopping GLP-1 drugs can quickly erase cardiovascular benefits

[
Following a rapid increase in popularity of GLP-1 drugs for diabetes and weight loss, such as semaglutide and tirzepatide, approximately one in eight U.S. adults now take these medications, which also provide cardiovascular benefits. However, when patients stop taking these drugs, they not only regain weight, but, according to a new study, they also incur increased risk of heart attack, stroke, and death compared to staying on the medication.


Source link

Advertisements
Views: 2

See also  Methadone tied to lower risk for discontinuation versus buprenorphine/naloxone

Check Also

New antibiotic design could help treat drug-resistant infections

[ Credit: Pixabay/CC0 Public Domain A new way of designing antibiotics could support the discovery …

Lab-grown brain organoids power biocomputers

[ A feature story authored by Simon Spichak, MSc investigates how biotech companies like Cortical …

Recommendations developed for assessing postoperative Crohn disease recurrence

[ Multidisciplinary recommendations are presented to standardize intestinal ultrasound application for assessing postoperative recurrence of …

Leave a Reply

Available for Amazon Prime
Lexonads | free ad network | automated website traffic.